Inventor · disambiguated record
Richard Jonathan Hatley
Also filed as: HATLEY RICHARD · HATLEY RICHARD J · HATLEY RICHARD JONATHAN · HATLEY RICHARD JONATHAN DANIEL
4 granted patents·6 pending applications·30 citations·filing 2002–2021
75Inventor score
Files withHATLEY RICHARD JONATHAN DANIEL3GLAXO GROUP LTD2SMITHKLINE BEECHAM CORP2GLAXOSMITHKLINE IP DEV LTD1HATLEY RICHARD1
Top patents by PatentIndex Score
10 records- 0185US8367673B2Substituted diketopiperazines as oxytocin antagonistsGLAXO GROUP LTD·Filed 2009·Granted Feb 5, 2013·8 cites·11 claims
- 0283US8541579B2Substituted diketopiperazines as oxytocin antagonistsGLAXO GROUP LTD·Filed 2012·Granted Sep 24, 2013·6 cites·1 claims
- 0381US7514437B2Substituted diketopiperazines as oxytocin antagonistsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Apr 7, 2009·15 cites·12 claims
- 0465US8143264B2Xanthine derivatives as selective HM74A agonistsHATLEY RICHARD JONATHAN DANIEL·Filed 2006·Granted Mar 27, 2012·1 cites·16 claims
- 0553US2023257375A1Azetidine derivatives for the treatment of integrin associated diseasesUNIV NOTTINGHAM·Filed 2021·Application pending·0 cites
- 0644US2007191378A1Anthranilic acid derivatives and their use as activators of the hm74a receptorSMITHKLINE BEECHAM CORP·Filed 2004·Application pending·0 cites
- 0743US2008221108A1Anthranilic Acid Derivatives As Hm74A Receptor AgonistsHATLEY RICHARD·Filed 2006·Application pending·0 cites
- 0841US2020291017A1Citrate salt of the compound (s)-4-((s)-3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthydrin-2-yl)ethyl)pyrrolidin-1-yl)-3-(3-(2-methoxyethoxy)phenyl) butanoic acidGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Application pending·0 cites
- 0938US2011257205A1Xanthine derivatives as selective hm74a agonistsHATLEY RICHARD JONATHAN DANIEL·Filed 2011·Application pending·0 cites
- 1036US2009209561A1Xanthine Derivatives with HM74A Receptor ActivityHATLEY RICHARD JONATHAN DANIEL·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →